180 Life Sciences (ATNF) Financials

$16.80

$14.97 (818.03%)

As on 17-Oct-2025 09:30EDT

Market cap

$1,077 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

--

P/B Ratio

76.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	4.21	--	--	--	--	--
Cost of Revenue	0.05	0.06	0.11	0.11	0.12	--
Gross Profit	0.05	-0.06	-0.11	-0.11	-0.12	--
Operating Expenses	230.11	6.27	13.37	17.90	5.65	5.65
Operating Profit (EBIT)	-226.00	-6.32	-13.48	-17.90	-5.65	-5.65
Other Income	--	--	--	--	--	--
Profit before Tax	-217.34	-6.46	-22.28	-39.67	-10.90	-10.90
Provision for Tax	7.48	-0.30	-2.35	-0.94	-0.02	-0.02
Profit after Tax (Net Income)	-225.11	-6.17	-19.94	-38.73	-10.88	-10.88
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-20.32	-12.01

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	445.14	9.25	-0.13	11.34	39.32	30.29
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	508.39	0.01	0.32	2.65	3.69	3.83
Current Liabilities	55.79	3.50	5.06	5.66	19.70	21.42
Total Liabilities	1,065.10	12.76	5.26	19.65	62.71	55.53

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	447.36	7.62	1.62	10.72	51.51	51.52
Current Assets	561.95	5.14	3.64	8.93	11.20	4.01
Total Assets	1,571.26	12.76	5.26	19.65	62.71	25.25
Total Debt*	496.76	0.15	1.05	1.34	1.96	3.78
Net Current Assets	--	1.64	-1.42	3.27	-8.50	-17.41

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-1.48	-10.92	-12.13	-3.87	-3.87
Cash Flow from Investing Activities	--	--	--	--	14.49	14.49
Cash from Financing Activities	--	4.04	5.91	10.87	-8.73	-8.73
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-22.78	-6.29	-32.00	-329.87	-121.88	-12,093.40
Cash EPS ($)	--	-6.23	-31.81	-328.94	-120.65	-11,954.14
Adjusted Book Value ($)	--	9.43	--	96.63	440.34	33,652.08
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.51	-17.53	-103.30	-43.36	-4,302.18
Free Cash Flow per Share ($)	--	-1.51	-17.53	-103.30	-43.36	-4,302.18

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-119.39	-292.95	-143.53	-28.89	-28.58
ROE (%)	-99.42	-135.21	-355.47	-152.87	-31.27	-31.61
ROA (%)	-28.35	-68.45	-160.06	-94.04	-18.41	-20.26
EBIT Margin (%)	-206.29	--	--	--	--	--
Net Margin (%)	-5,353.06	--	--	--	--	--
Cash Profit Margin (%)	1.71	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	1,166.42	--	--	--	--	--
EBIT Growth (%)	-182.15	70.71	-24.26	-82.31	-82.37	74.20
Net Profit Growth (%)	-7,110.98	69.06	48.52	-255.81	--	57.14
EPS Growth (%)	-407.85	0.80	0.90	-1.71	0.99	0.24
Book Value Growth (%)	841.44	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.29	-0.01	-0.01	-0.03	0.00
Price / Book Value	76.81	0.19	-1.04	0.04	0.01	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.46	0.42	0.04	0.29	0.61	-0.32
Close Price ($)	2.51	1.82	4.07	64.41	1,482.00	1,037.40
High Price ($)	17.75	17.75	135.85	1,533.68	4,957.21	4,370.00
Low Price ($)	0.66	1.16	2.85	22.42	915.80	722.00
Market Cap ($ Cr)	1,077.35	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.02	-8.25	0.12	0.05	0.12
Short term debt to equity ratio	0.00	0.02	-8.10	0.12	0.05	0.12
Current Ratio	10.07	1.47	0.72	1.58	0.57	0.19
Quick Ratio	10.07	--	--	1.69	0.46	--
Interest Coverage	-648.86	-128.65	-494,215.60	-671.17	-9.03	-4.95

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.01	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	-2,146.29	2,699.57	7,010.81	--
Payable days	--	11,988.91	6,383.57	4,000.55	14,314.95	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.